Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2FW | ISIN: US87241J2033 | Ticker-Symbol: 0K30
Lang & Schwarz
06.06.25 | 07:00
1,700 Euro
-100,00 % -1,700
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TFF PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
TFF PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,5501,85006.06.

Aktuelle News zur TFF PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.03.TFF Pharmaceuticals, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities-
TFF PHARMACEUTICALS Aktie jetzt für 0€ handeln
06.03.TFF Pharmaceuticals, Inc. - 8-K, Current Report-
06.02.TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration105FOXBOROUGH, Mass., Feb. 6, 2025 /PRNewswire/ -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has provided notification to The Nasdaq...
► Artikel lesen
03.02.TFF Pharmaceuticals, Inc. - 8-K, Current Report-
10.12.24TFF Pharmaceuticals, Inc. - 8-K, Current Report1
14.11.24TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces It Will Wind Down Operations186FORT WORTH, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has terminated its employees and will wind down its operations. This...
► Artikel lesen
26.09.24TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals' Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery295FORT WORTH, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the "Company" or "TFF Pharmaceuticals"), a clinical-stage biopharmaceutical company focused on developing...
► Artikel lesen
10.09.24TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization183TFF-dry powder HA antigen vaccine candidates induced neutralizing antibody titers in ferrets against H1 and H3 influenza strains Ongoing funded work to assess additional influenza strains FORT WORTH...
► Artikel lesen
06.08.24TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection257Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved >80% of the previous oral trough blood...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1